WEX Pharmaceuticals Inc. is a late-stage drug development company in Vancouver, Canada dedicated to the research, development, manufacture, and commercialization of Halneuron®, a new novel non-opioid analgesic.
Halneuron® is a highly selective sodium channel blocker and represents a breakthrough in painkiller technology:
- Non-addictive, no withdrawal symptoms and no euphoria
- No build of up of tolerance over time
- A long duration of pain relief with minimal side effects
- Safe for human use and tested in over 700 people to date
Halneuron® is entering into Phase III clinical trials for chemotherapy-induced neuropathic pain and concurrently being tested in other pain indications.
Company Details
- Employees
- 22
- Founded
- -
- Address
- 1100 Melville St, 1150,canada
- Phone
- 1 604-683-8880
- fa****@****rma.com
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- wexpharma.com
- HQ
- Vancouver, British Columbia
Wex Pharmaceuticals Inc. Questions
Wex Pharmaceuticals Inc.'s helpline number is 1 604-683-8880
Wex Pharmaceuticals Inc.'s website is wexpharma.com
Wex Pharmaceuticals Inc.'s LinkedIn profile is https://ca.linkedin.com/company/wex-pharmaceuticals-inc.
Wex Pharmaceuticals Inc. has
22 employees.
View email and phone details for 22
employees at Wex Pharmaceuticals Inc..
Wex Pharmaceuticals Inc.'s industry is
Biotechnology Research
Wex Pharmaceuticals Inc.'s top competitors are
Aequus Pharmaceuticals,
Zucara Therapeutics Inc.,
Abdera Therapeutics,
Xenon Pharmaceuticals Inc.,
Nanovation Therapeutics™,
Eupraxia Pharmaceuticals Inc.,
Acuitas Therapeutics,
Nervgen Pharma Corp.,
Dogwood Therapeutics,
Zymeworks Inc..
Wex Pharmaceuticals Inc.'s support email address is facebook@wexpharma.com
Wex Pharmaceuticals Inc.'s categories are Biotechnology Research
Wex Pharmaceuticals Inc.'s founding year is 1987
